Remove 2019 Remove Hospital Remove Individual Remove Provider
article thumbnail

Outcomes associated with timing of screening for gestational diabetes [Women's health]

Annals of Family Medicine

Dataset: A combined dataset consisting of prenatal data from a primary care database and intrapartum data from a provincial hospital administrative database. Significance was set as p < 0.05.Dataset: Exclusion criteria included a pre-pregnancy diagnosis of type 1 or type 2 diabetes.

Screening 130
article thumbnail

Declines in intensive care unit admissions in early COVID-19 pandemic among persons with dementia in three Canadian provinces [Acute and emergency care]

Annals of Family Medicine

Context: Providing critical care for people living with dementia (PLWD) during the COVID-19 pandemic outbreak was raised as a global concern. Step 1: Compared rates of ICU admissions in three 2020 periods (1st wave; interim period; 2nd wave) to the corresponding 2019 periods. Setting: Alberta, Ontario, Quebec.

Community 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

An Evaluation of Gonorrhea and Chlamydia Incidence, Treatment, and Guideline Adherence in an Ambulatory Healthcare System [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Population Studied: Individuals with gonorrhea and chlamydia positive tests. Results: Between 1/1/2019 and 12/31/2021, 4385 persons were treated for chlamydia and gonorrhea were documented within the MedStar system. 52.7% (n=2311/4385) were diagnosed in a Hospital / ED setting, 25.2% (1107) within a primary care setting, and 18.1%

article thumbnail

Minnesota Proposes to Reduce Opioid Product Registration Fees Related to Hospitals

FDA Law Blog

Richardson — A recent proposed amendment to Minnesota’s Opiate Product Registration Fee appears intended to ensure continued availability of certain opiate products at hospitals. If enacted, Article 5, Section 6 of HF33 would provide for a reduction to the State’s opiate product registration fee. 151.066, Subd.

article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

Michael’s Hospital in Unity Health Toronto, and Dr. Alika Lafontaine, the current President of the Canadian Medical Association. The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon.

Medical 52
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

A multilayered view of stigmatizing discourses lays the foundation for eliciting a series of suggestions for quelling stigma, to be implemented at the individual, community, and national levels, as suggested by the WHO. Psychological health during the coronavirus disease 2019 pandemic outbreak. Scholars such as Wen et al.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. This comparison is misplaced. If finalized, the PR may also be subject to broader challenges.